| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.26▲ | 1.24▲ | 1.24▲ | 1.18▲ | 1.46▼ |
| MA10 | 1.25▲ | 1.26▲ | 1.21▲ | 1.37▼ | 2.62▼ |
| MA20 | 1.24▲ | 1.20▲ | 1.18▲ | 1.53▼ | 7.75▼ |
| MA50 | 1.22▲ | 1.24▲ | 1.33▼ | 3.27▼ | 18.45▼ |
| MA100 | 1.20▲ | 1.44▼ | 1.52▼ | 9.12▼ | 83.31▼ |
| MA200 | 1.43▼ | 2.04▼ | 2.79▼ | 15.12▼ | 721.22▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.011▲ | 0.025▲ | 0.136▲ | 0.736▲ |
| RSI | 52.759▲ | 54.245▲ | 53.457▲ | 24.543▼ | 27.594▼ |
| STOCH | 90.833▲ | 26.876 | 32.668 | 21.840 | 2.029▼ |
| WILL %R | -14.286▲ | -64.103 | -58.140 | -61.644 | -98.246▼ |
| CCI | 100.312▲ | 33.229 | 65.125 | -46.057 | -76.181 |
|
Tuesday, August 20, 2019 05:36 AM
SAN FRANCISCO, CA / ACCESSWIRE / August 20, 2019 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”), a commercial stage pharmaceutical company focused on developing novel, sustainably ...
|
|
Tuesday, August 20, 2019 05:32 AM
SAN FRANCISCO, CA / ACCESSWIRE / August 20, 2019 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company"), a commercial stage pharmaceutical company focused on developing novel, sustainably ...
|
|
Monday, August 19, 2019 10:52 AM
Nano cap Jaguar Health (NASDAQ:JAGX) is up 16% premarket on light volume in response to encouraging preclinical data on the effects of crofelemer in healthy dogs with induced diarrhea from a ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/08/19 | 1.49 | 1.56 | 1.18 | 1.28 | 11,916,400 |
| 20/08/19 | 1.11 | 1.20 | 1.08 | 1.15 | 2,284,578 |
| 19/08/19 | 1.29 | 1.45 | 1.08 | 1.15 | 3,815,200 |
| 16/08/19 | 1.22 | 1.27 | 1.00 | 1.11 | 859,368 |
| 15/08/19 | 1.45 | 1.47 | 1.11 | 1.21 | 963,485 |
| 14/08/19 | 1.65 | 1.655 | 1.49 | 1.52 | 513,600 |
| 13/08/19 | 1.51 | 1.63 | 1.48 | 1.59 | 504,022 |
| 12/08/19 | 1.58 | 1.59 | 1.48 | 1.52 | 475,400 |
| 09/08/19 | 1.62 | 1.62 | 1.48 | 1.54 | 649,700 |
| 08/08/19 | 1.71 | 1.73 | 1.56 | 1.59 | 596,328 |
|
|
||||
|
|
||||
|
|